NCT06159829

Brief Summary

Background: Virtual reality (VR) is a tool that uses three-dimensional computer graphics-based technologies to make an individual feel as if they are physically in the virtual environment by misleading their senses. In recent years, the use of VR has been widely used in clinical applications such as anxiety disorders, pain, and stress coping VR can be used to relieve acute pain and anxiety in hospitalized patients and was shown in several studies to reduce pain and anxiety levels Aim: to evaluate the effect of virtual reality on anxiety and pain in patients who underwent upper endoscopy without sedation. Design: A single-centre, parallel-group, randomised control trial. Methods: The study sample consisted of 100 patients assigned to the intervention group (n=50) or control group (n=50) by stratified block randomization to control for sex distribution. During the upper endoscopy procedure, patients in the intervention group watched a video of natural scenery through virtual reality goggles. The study outcomes were anxiety and pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 22, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2022

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

November 15, 2023

Completed
22 days until next milestone

First Posted

Study publicly available on registry

December 7, 2023

Completed
Last Updated

December 7, 2023

Status Verified

November 1, 2023

Enrollment Period

6 months

First QC Date

November 15, 2023

Last Update Submit

November 28, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Comparison of mean pain scores of patients in the intervention and control groups of during endoscopy

    Visuel Analog Scale (VAS) This one-dimensional measure of pain intensity is a reliable and easily applicable scale that is widely accepted in the literature. VAS is used to convert nonmeasurable variables into numeric values. The 10cm scale is labeled 0 ("no pain") at one end and 10 ("extreme pain") at the other, with values indicated at each cm in between

    Patients' pain levels were evaluated immediately after the procedure was completed.

Secondary Outcomes (1)

  • Comparison of mean anxiety scores of patients in the intervention and control groups of during endoscopy

    Patients' anxiety levels were evaluated immediately after the procedure was completed.

Study Arms (2)

Virtual Reality

EXPERIMENTAL

Virtual Reality glasses

Behavioral: experimental

Control

NO INTERVENTION

Patients in the control group underwent upper endoscopy following the standard protocol.

Interventions

experimentalBEHAVIORAL

intervention group used VR with a natural landscape and relaxing musical accompaniment during the upper endoscopy procedure.

Virtual Reality

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Not using analgesics before the procedure,
  • Not using anticoagulants within the last 24 hours,
  • Having no vision or hearing problems
  • Not receiving sedation
  • Having no cognitive or psychiatric disorder that may affect understanding and communication

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Figen Erol Ursavaş

Aksu, Çankırı, 18200, Turkey (Türkiye)

Location

Study Officials

  • Figen Erol Ursavaş

    Cankırı Karatekin Univeristy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

November 15, 2023

First Posted

December 7, 2023

Study Start

June 22, 2022

Primary Completion

December 30, 2022

Study Completion

December 30, 2022

Last Updated

December 7, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations